| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |